Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FBLN3 antibody (AA 258-493)

This Mouse Monoclonal antibody specifically detects FBLN3 in WB. It exhibits reactivity toward Human.
Catalog No. ABIN7617400

Quick Overview for FBLN3 antibody (AA 258-493) (ABIN7617400)

Target

See all FBLN3 Antibodies
FBLN3 (Fibulin 3 (FBLN3))

Reactivity

  • 58
  • 22
  • 14
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 2
  • 2
  • 1
Human

Host

  • 53
  • 7
Mouse

Clonality

  • 45
  • 15
Monoclonal

Conjugate

  • 35
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FBLN3 antibody is un-conjugated

Application

  • 55
  • 39
  • 21
  • 18
  • 10
  • 9
  • 8
  • 5
  • 3
  • 2
  • 1
Western Blotting (WB)

Clone

C7
  • Binding Specificity

    • 9
    • 6
    • 5
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 258-493

    Purpose

    Fibulin 3 (FBLN3) Monoclonal Antibody

    Sequence

    Cys258~Phe493

    Characteristics

    The Fibulin 3 (FBLN3) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB.

    Purification

    Protein A + Protein G affinity chromatography

    Isotype

    IgG1 lambda
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    FBLN3 (Fibulin 3 (FBLN3))

    Alternative Name

    FBLN3

    Gene ID

    2202

    UniProt

    Q12805

    Pathways

    EGFR Signaling Pathway
You are here:
Chat with us!